# Bio-Rad Laboratories

美国生命科学产品公司（NYSE: BIO，1952年创立）——Nuvia混合模式和离子交换层析树脂、NGC FPLC系统、CHT陶瓷羟基磷灰石用于单抗精制；广泛的诊断和生命科学研究产品组合。

Source: https://cn.bioecon.ru/companies/bio-rad/
Updated: 2026-06-19

- 国家: United States
- 营收: $2.8B
- 员工: ~7,800 emp

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 营收 | 2025年$25.8亿 | https://www.sec.gov/Archives/edgar/data/12208/000001220826000021/bio-radannualreport2025.pdf |
| 员工人数 | 截至2025年12月31日约7,450名员工 | https://www.sec.gov/Archives/edgar/data/12208/000001220826000021/bio-radannualreport2025.pdf |
| 生产基地 | 全球制造网络，涵盖加利福尼亚州Hercules与Irvine、华盛顿州西雅图/Woodinville，以及新加坡、法国、德国、瑞士、比利时和中国的设施 | https://www.bio-rad.com/en-us/feature/quality-management-systems-certificates.html, https://www.sec.gov/Archives/edgar/data/12208/000001220826000021/bio-radannualreport2025.pdf |
| 认证 | ISO 9001、ISO 13485:2016及符合医疗器械单一审核程序（MDSAP） | https://www.bio-rad.com/en-us/feature/quality-management-systems-certificates.html, https://www.bio-rad.com/sites/default/files/2025-06/QS6_118577_0016.pdf, https://www.sec.gov/Archives/edgar/data/12208/000001220826000021/bio-radannualreport2025.pdf |
| 监管批准 | 产品受FDA（CDRH/CBER）监管；诊断产品符合欧盟IVDR要求 | https://www.sec.gov/Archives/edgar/data/12208/000001220825000019/bio-rad2024annualreport10xk.pdf, https://www.sec.gov/Archives/edgar/data/12208/000001220826000021/bio-radannualreport2025.pdf |
| 融资 | 投资Geneoscopy与Oncocyte；宣布拟收购Stilla Technologies（截至2025年2月） [中等置信度] | https://investors.bio-rad.com/press-releases/news-details/2025/Bio-Rad-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results/default.aspx, https://investors.bio-rad.com/press-releases/news-details/2026/Bio-Rad-Reports-Second-Quarter-2026-Financial-Results/, https://www.sec.gov/Archives/edgar/data/12208/000001220826000021/bio-radannualreport2025.pdf |
| 产能 | 产能按设施正常产能进行管理；受生产基地整合影响（如将欧洲基地并入新加坡枢纽） [中等置信度] | https://www.bio-rad.com/webroot/web/pdf/corporate/literature/2004_annual.pdf |

独立来源: sec.gov

## 技术

- [基于eDNA的入侵物种生物监测](https://cn.bioecon.ru/technology/edna-invasive-species-biomonitoring/)
- [家用DNA提取套件](https://cn.bioecon.ru/technology/home-dna-extraction-kits/)
- [污水流行病学](https://cn.bioecon.ru/technology/wastewater-based-epidemiology/)
- [生物制药下游纯化与生物分离（DSP）](https://cn.bioecon.ru/technology/downstream-purification-bioseparation/)